Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Jun. 30, 2018	Aug. 10, 2018	Dec. 31, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Lifevantage Corp
Entity Central Index Key	0000849146
Document Type	10-K
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 67.6
Entity Common Stock, Shares Outstanding		14,088,430

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Current assets
Cash and cash equivalents	$ 16,652	$ 11,458
Accounts receivable	2,067	1,334
Income tax receivable	451	913
Inventory, net	13,627	16,575
Prepaid expenses and deposits	6,141	5,266
Total current assets	38,938	35,546
Long-term assets
Property and equipment, net	6,587	3,127
Intangible assets, net	1,115	1,247
Long-term deferred income tax asset	3,255	4,087
Other long-term assets	1,247	1,242
TOTAL ASSETS	51,142	45,249
Current liabilities
Accounts payable	3,813	4,850
Commissions payable	7,546	6,837
Income tax payable	39	215
Other accrued expenses	10,407	9,453
Current portion of long-term debt	2,000	2,000
Total current liabilities	23,805	23,355
Long-term debt
Principal amount	3,500	5,500
Less: unamortized discount and deferred offering costs	(88)	(60)
Long-term debt, net of unamortized discount and deferred offering costs	3,412	5,440
Other long-term liabilities	1,978	1,927
Total liabilities	29,195	30,722
Commitments and contingencies — Note 11
Stockholders’ equity
Preferred stock — par value $0.0001 and $0.001 per share, 5,000 and 50,000 shares authorized, no shares issued or outstanding	0	0
Common stock — par value $0.0001 and $0.001 per share, 40,000 and 250,000 shares authorized and 14,073 and 14,232 issued and outstanding as of June 30, 2018 and 2017, respectively	1	14
Additional paid-in capital	124,663	121,599
Accumulated deficit	(102,731)	(106,992)
Accumulated other comprehensive income (loss)	14	(94)
Total stockholders’ equity	21,947	14,527
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 51,142	$ 45,249

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2018	Jun. 30, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value (dollars per share)	$ 0.0001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (dollars per share)	$ 0.0001	$ 0.001
Common stock, shares authorized (in shares)	40,000,000	250,000,000
Common stock, shares issued (in shares)	14,073,000	14,232,000
Common stock, shares outstanding (in shares)	14,073,000	14,232,000

Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenue, net	$ 203,204	$ 199,489	$ 206,540
Cost of sales	34,848	33,456	33,932
Gross profit	168,356	166,033	172,608
Operating expenses:
Commissions and incentives	98,193	96,662	103,120
Selling, general and administrative	59,840	64,922	56,074
Total operating expenses	158,033	161,584	159,194
Operating income	10,323	4,449	13,414
Other expense:
Interest expense	(456)	(570)	(3,321)
Other expense, net	(319)	(969)	(1,409)
Total other expense	(775)	(1,539)	(4,730)
Income before income taxes	9,548	2,910	8,684
Income tax expense	(3,787)	(1,302)	(2,578)
Net income	$ 5,761	$ 1,608	$ 6,106
Net income per share:
Basic (dollars per share)	$ 0.41	$ 0.12	$ 0.44
Diluted (dollars per share)	$ 0.41	$ 0.11	$ 0.42
Weighted-average shares outstanding:
Basic (in shares)	13,992	13,881	13,730
Diluted (in shares)	14,136	14,118	14,531
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	$ 108	$ (87)	$ 244
Other comprehensive income (loss), net of tax:	108	(87)	244
Comprehensive income	$ 5,869	$ 1,521	$ 6,350

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balances, shares at Jun. 30, 2015		13,958,000
Beginning balances at Jun. 30, 2015	$ 1,806	$ 14	$ 116,749	$ (114,706)	$ (251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,966		1,966
Exercise of options and warrants, shares		52,000
Exercise of options and warrants	527		527
Issuance of shares related to restricted stock, shares		76,000
Issuance of shares related to restricted stock	0
Shares canceled or surrendered as payment of tax withholding, shares		(58,000)
Currency translation adjustment	244				244
Net income	6,106			6,106
Ending balances, shares at Jun. 30, 2016		14,028,000
Ending balances at Jun. 30, 2016	10,649	$ 14	119,242	(108,600)	(7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,315		2,315
Exercise of options and warrants, shares		76,000
Exercise of options and warrants	42		42
Issuance of shares related to restricted stock, shares		166,000
Issuance of shares related to restricted stock	0
Shares canceled or surrendered as payment of tax withholding, shares		(38,000)
Currency translation adjustment	(87)				(87)
Net income	1,608			1,608
Ending balances, shares at Jun. 30, 2017		14,232,000
Ending balances at Jun. 30, 2017	14,527	$ 14	121,599	(106,992)	(94)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,990		2,990
Exercise of options and warrants, shares		21,000
Exercise of options and warrants	61		61
Issuance of shares related to restricted stock, shares		190,000
Issuance of shares related to restricted stock	$ 0
Shares canceled or surrendered as payment of tax withholding, shares		(66,000)
Repurchase of company stock, shares	(300,000)	(304,000)
Repurchase of company stock	$ (1,500)			(1,500)
Change in par value of common stock	0	$ (13)	13
Currency translation adjustment	108				108
Net income	5,761			5,761
Ending balances, shares at Jun. 30, 2018		14,073,000
Ending balances at Jun. 30, 2018	$ 21,947	$ 1	$ 124,663	$ (102,731)	$ 14

Consolidated Statements of Cash Flows - USD ($) shares in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Cash Flows from Operating Activities:
Net income	$ 5,761,000	$ 1,608,000	$ 6,106,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,325,000	1,643,000	1,895,000
Loss on disposal of fixed assets	0	0	1,186,000
Stock-based compensation	3,196,000	2,647,000	2,621,000
Amortization of deferred financing fees	11,000	12,000	232,000
Amortization of debt discount	21,000	19,000	183,000
Write-off of capitalized debt transaction costs pursuant to debt refinance	0	0	1,544,000
Write-off of intangible assets	0	350,000	0
Deferred income tax	831,000	(740,000)	(2,118,000)
Changes in operating assets and liabilities:
Accounts receivable	(730,000)	160,000	(409,000)
Income tax receivable	462,000	(912,000)	2,179,000
Inventory, net	2,953,000	8,309,000	(15,650,000)
Prepaid expenses and deposits	(993,000)	3,318,000	(356,000)
Other long-term assets	109,000	103,000	258,000
Accounts payable	(1,024,000)	(6,210,000)	3,673,000
Income tax payable	(175,000)	(3,132,000)	1,481,000
Other accrued expenses	1,935,000	135,000	2,243,000
Other long-term liabilities	(426,000)	(713,000)	968,000
Net Cash Provided by Operating Activities	13,256,000	6,597,000	6,036,000
Cash Flows from Investing Activities:
Purchase of equipment	(4,649,000)	(1,055,000)	(562,000)
Net Cash Used in Investing Activities	(4,649,000)	(1,055,000)	(562,000)
Cash Flows from Financing Activities:
Proceeds from term loan	0	0	10,000,000
Payment of deferred financing fees	(60,000)	0	(99,000)
Excess tax benefits from stock-based compensation	0	0	266,000
Repurchase of company stock	(1,500,000)	0	0
Payment on term loan	(2,000,000)	(2,000,000)	(22,125,000)
Exercise of options and warrants	61,000	42,000	261,000
Net Cash Used in Financing Activities	(3,499,000)	(1,958,000)	(11,697,000)
Foreign Currency Effect on cash	86,000	(9,000)	201,000
Increase (decrease) in cash and cash equivalents	5,194,000	3,575,000	(6,022,000)
Cash and Cash Equivalents — beginning of period	11,458,000	7,883,000	13,905,000
Cash and Cash Equivalents — end of period	16,652,000	11,458,000	7,883,000
Non Cash Investing and Financing Activities:
Increase in property and equipment/other long-term liabilities	0	116,000	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	345,000	438,000	1,342,000
Cash paid for income taxes	$ 2,865,000	$ 5,496,000	$ 1,368,000
Common stock shares issued upon cashless warrant exercises	0	53	6
Total cashless exercise price of warrants	$ 0	$ 88,000	$ 9,000
Gross warrants underlying cashless exercises	0	63	6

The Company	12 Months Ended
The Company	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company	The Company LifeVantage Corporation (the "Company") is a company focused on biohacking the aging code through nutrigenomics, the study of how nutrition and naturally occurring compounds affect our genes. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products and a financially rewarding direct sales business opportunity to customers and independent distributors. The Company sells its products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany and Taiwan. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through our e-commerce business model. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim^®, its line of scientifically-validated dietary supplements, TrueScience^®, its line of anti-aging skin care products, Petandim^™ for Dogs, its companion pet supplement formulated to combat oxidative stress in dogs, Axio^®, its Smart Energy Drink mixes, PhysIQ^™, its Smart Weight Management System, and Omega+, its sustainable fish oil supplement. The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation. On March 9, 2018, following approval by the Company's stockholders and its 2018 Annual Meeting of Stockholders, the Company changed its state of incorporation from the State of Colorado to the State of Delaware pursuant to a plan of conversion. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company's common stock was adjusted to $0.0001. All directors and officers of the Colorado corporation held the same position within the Delaware corporation on the date of reincorporation.

Summary of Significant Accounting Policies

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. Certain other prior period balances have also been reclassified to conform to the current period presentation.

Use of Estimates

The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, share-based compensation, and loss contingencies. During the fiscal year ended June 30, 2018 the Company made updates to its transfer pricing methodology and related estimates which resulted in adjustments made to certain previously accrued liabilities.

Foreign Currency Translation

A portion of the Company’s business operations occurs outside the United States. The local currency of each of the Company’s subsidiaries is generally its functional currency. All assets and liabilities are translated into U.S. Dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.

Fair Value of Financial Instruments

Accounting guidance on fair value measurements and disclosures requires disclosures about the fair value for all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about fair value of financial instruments are based on pertinent information available to management as of June 30, 2018 and 2017. Accordingly, the estimates presented in these consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments.

Management has estimated the fair values of cash and cash equivalents, accounts receivable, accounts payable, commissions payable and other accrued expenses to approximate their respective carrying values reported in these consolidated financial statements because of their short maturities.

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less to be cash and cash equivalents.

Accounts Receivable

The Company’s accounts receivable for the fiscal years ended June 30, 2018 and 2017 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June 30, 2018 or 2017 is not necessary. No bad debt expense was recorded for the fiscal years ended June 30, 2018, 2017 and 2016.

Inventory

As of June 30, 2018 and 2017, inventory consisted of (in thousands):



	June 30,
	2018		2017
Finished goods	$	7,859	$	7,817
Raw materials	5,768		8,758
Total inventory	$	13,627	$	16,575

Inventories are carried and depicted above at the lower of cost or market, using the first-in, first-out method, which includes a reduction in inventory values of $1.4 million and $0.9 million at June 30, 2018 and 2017, respectively, related to obsolete and slow-moving inventory.

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:



	Years
Equipment (includes computer hardware and software)	3
Furniture and fixtures	5
Vehicles	5

Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.

The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. During the fiscal years ended June 30, 2018 and 2017, there were no losses on disposal of assets. During the fiscal year ended June 30, 2016, the Company recognized a loss on disposal of $1.2 million related to the write-off of previously capitalized software development costs incurred.

Intangible Assets

Intangible assets are stated at cost less accumulated amortization. Definite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset’s carrying value and estimated fair value.

Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Annual impairment tests were completed for the fiscal year ended June 30, 2018 resulting in no impairment charges. During the fiscal year ended June 30, 2017, the Company recognized a loss of $0.4 million upon write-off of previously capitalized indefinite-lived intangible assets.

Impairment of Long-Lived Assets

Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow. Except as noted above, for the fiscal years ended June 30, 2018 and 2017, management has concluded that there are no indications of impairment.

Concentration of Credit Risk

Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and cash equivalents. At June 30, 2018, the Company had $11.4 million in cash accounts at one financial institution and $5.3 million in other financial institutions. As of June 30, 2018 and 2017, and during the years then ended, the Company’s cash balances exceeded federally insured limits.

Revenue Recognition

The Company ships the majority of its product directly to the consumer and receives substantially all payment for these sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company’s return policy is to provide a full refund for product returned within 30 days if the returned product is unopened or defective. After 30 days, the Company generally does not issue refunds to direct sales customers for returned product. The Company allows terminating distributors to return up to 30% of unopened, unexpired product that they have purchased within the prior twelve months for a full refund, less a 10% restocking fee. The Company establishes the returns reserve based on historical experience. The returns reserve is evaluated on a quarterly basis. As of June 30, 2018 and 2017, the Company’s reserve balance for returns and allowances was $0.4 million and $0.4 million, respectively.

Commissions and Incentives

Commissions and incentives expenses are the Company’s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company's independent distributors, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent distributors for personal purchases. Commissions paid to independent distributors on personal purchases are considered a sales discount and are reported as a reduction to net revenue.

Shipping and Handling

Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.

Research and Development Costs

The Company expenses all costs related to research and development activities as incurred. Research and development expenses for the fiscal years ended June 30, 2018, 2017 and 2016 were $1.2 million, $1.1 million and $1.0 million, respectively.

Stock-Based Compensation

The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.

The Black-Scholes option pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The Company uses historical data for estimating the expected life of stock options. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.

The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company’s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.

Reverse Stock Split

In October 2015, following approval of the Company's shareholders, the Company's board of directors approved the filing of an amendment to the Company's amended and restated articles of incorporation to effectuate a reverse split of the issued and outstanding shares of the Company's common stock on a one-for-seven basis. The reverse stock split was effective on October 19, 2015. The par value and authorized number of shares of common stock were not adjusted as a result of the reverse split. All fractional shares resulting from the reverse stock split were rounded up. All issued and outstanding common stock and per share amounts contained within the Company's consolidated financial statements and footnotes have been retroactively adjusted to reflect this reverse stock split for all periods presented.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.

On December 22, 2017, the President of the United States of America signed tax reform legislation (the “2017 Tax Act”), which includes a broad range of tax reform affecting businesses, including corporate tax rates, business deductions, and international tax regulations. Among these changes, the 2017 Tax Act reduces the corporate tax rate from 35% to 21% effective December 31, 2017. Current taxes for fiscal 2018 are accounted for at a blended rate of 28%, and the Company has revalued its deferred tax assets and liabilities to the reduced rates based on the period in which those assets and liabilities are expected to reverse. The Company has incorporated all other changes resulting from the 2017 Tax Act in its tax related accounts for the fiscal year ended June 30, 2018.

Income Per Share

Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.

For the fiscal years ended June 30, 2018 and 2017, the effects of approximately 0.4 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock, are not included in the computations as their effect was anti-dilutive.

The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):



	Years ended June 30,
	2018		2017		2016

Numerator:
Net income	$	5,761	$	1,608	$	6,106
Denominator:
Basic weighted-average common shares outstanding	13,992		13,881		13,730
Effect of dilutive securities:
Stock awards and options	144		237		735
Warrants	—		—		66
Diluted weighted-average common shares outstanding	14,136		14,118		14,531
Net income per share, basic	$	0.41	$	0.12	$	0.44
Net income per share, diluted	$	0.41	$	0.11	$	0.42

Segment Information

The Company operates in a single operating segment by selling products to an international network of independent distributors that operates in an integrated manner from market to market. Commissions and incentives expenses are the Company’s largest expense comprised of the commissions paid to its independent distributors. The Company manages its business primarily by managing its international network of independent distributors. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in two geographic regions: the Americas region and the Asia/Pacific & Europe region. Revenues by geographic area are as follows (in thousands):



	Years ended June 30,
	2018		2017		2016
Americas	$	151,609	$	150,841	$	158,291
Asia/Pacific & Europe	51,595		48,648		48,249
Total revenues	$	203,204	$	199,489	$	206,540

Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):



	Years ended June 30,
	2018		2017		2016
United States	$	142,452	$	144,842	$	152,830
Japan	$	41,843	$	39,390	$	36,343

As of June 30, 2018, long-lived assets were $9.8 million in the U.S. and $0.9 million in Japan. As of June 30, 2017, long-lived assets were $6.2 million in the U.S. and $0.9 million in Japan.

Major Products

The Company's revenues are largely attributed to two product lines, Protandim^® and TrueScience^®, which each accounted for more than 10% of total revenues for each of the fiscal years ended June 30, 2018, 2017 and 2016. On a combined basis, these products represent approximately 76.6%, 77.9% and 77.9% of the Company's worldwide gross revenues for the fiscal years ended June 30, 2018, 2017 and 2016, respectively. The following table shows revenues by major product line for the fiscal years ended June 30, 2018, 2017 and 2016.



	Years ended June 30,
	2018				2017				2016
Protandim^®product line	$	133,923	65.9	%	$	130,873	65.6	%	$	128,019	62.0	%
TrueScience^®product line	21,665		10.7	%	24,440		12.3	%	32,914		15.9	%
Other	47,616		23.4	%	44,176		22.1	%	45,607		22.1	%
Total	$	203,204	100.0	%	$	199,489	100.0	%	$	206,540	100.0	%

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606), and has subsequently issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, ASU 2016-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815), ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers (collectively, Topic 606).

Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the new guidance is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration it expects to receive in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. This guidance is effective for the Company beginning on July 1, 2018 with the option to adopt using either a full retrospective or a modified retrospective approach. The Company expects to adopt Topic 606 using the modified retrospective approach, under which the cumulative effect of initially applying Topic 606 is recognized as an adjustment to the opening balance of retained earnings in the first quarter of fiscal 2019.

The Company has evaluated each of its revenue streams and has identified similar performance obligations under Topic 606 as compared to current revenue recognition guidance. During its evaluation, the Company reviewed its loyalty points program and, based on the new guidance, will change the method of accounting from a cost provision method to a deferred revenue method.

There are also considerations related to internal control over financial reporting associated with implementing Topic 606. The Company has substantially completed the evaluation of its control framework for revenue recognition and identified no material changes needed in response to the new guidance. The Company has also evaluated the expanded disclosure requirements under Topic 606 and has substantially completed the design and implementation of the appropriate controls over gathering and reporting the information required under Topic 606.

In February 2016, FASB issued ASU No. 2016-02, Leases (Topic 841). For lessees, this ASU requires that for all leases not considered to be short term, a company recognize both a right-of-use asset and lease liability on its balance sheet, representing the obligation to make payments and the right to use or control the use of a specified asset for the lease term. This ASU is effective for annual periods beginning after December 15, 2018 and interim periods within those annual periods. The Company is currently evaluating the impact of the ASU on the Company’s outstanding leases and expects that adoption will have an impact on its consolidated balance sheets related to recording right-of-use assets and corresponding lease liabilities.

In May 2017, FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The ASU provides guidance about which changes to the terms or conditions of a share-based award require an entity to apply modification accounting in Topic 718. An entity should account for the effects of a modification unless all the following are met: (1) The fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, (2) The vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified, (3) The classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under this ASU. This ASU will become effective for the Company beginning July 1, 2018 and will be applied to any award modified on or after that date.

Property and Equipment, Net

12 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Property and equipment, net consist of (in thousands):



	June 30,
	2018			2017
Equipment (includes computer hardware and software)	$	10,504		$	7,420
Furniture and fixtures	1,592			1,536
Leasehold improvements	3,761			3,421
Vehicles	51			51
Accumulated depreciation	(9,321		)	(9,301		)
Total property and equipment, net	$	6,587		$	3,127

Depreciation expense totaled $1.2 million, $1.5 million and $1.8 million for the fiscal years ended June 30, 2018, 2017 and 2016, respectively.

Long-Term Debt

12 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

Long-Term Debt

On March 30, 2016, the Company entered into a loan agreement (the "2016 Loan Agreement") to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the "2016 Security Agreement"). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the "2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the "2016 Revolving Loan," and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the 2016 Security Agreement, the "2016 Credit Facility").

The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June 30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.

On May 4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (“Amendment No. 1”). Amendment No. 1 revised the maturity date from March 30, 2019 to March 31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.

The Company’s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company’s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan, as amended, exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan, as amended, which is prepaid or repaid may not be re-borrowed.

The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company's ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company's assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain a certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility. As of June 30, 2018, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.

The Company’s book value for the 2016 Credit Facility, as amended, approximates the fair value. Aggregate future principal payments required in accordance with the terms of the 2016 Credit Facility, as amended, are as follows (in thousands):



Year ending June 30,	Amount
2019	$	2,000
2020	2,000
2021	1,500
	$	5,500

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Jun. 30, 2018
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity During the fiscal years ended June 30, 2018, 2017 and 2016, the Company issued 21,000, 0.1 million and 0.1 million shares, respectively, of common stock as a result of the exercise of options and warrants. During the fiscal years ended June 30, 2018, 2017 and 2016, the Company issued 0.2 million, 0.2 million and 0.1 million shares, respectively, of restricted stock. During the fiscal years ended June 30, 2018, 2017 and 2016, 0.1 million, 38,000 and 0.1 million shares, respectively of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company may enter into a pre-arranged stock repurchase plan which will operate in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, transactions, if any, would be completed in accordance with the terms of the stock repurchase plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time and expires on November 27, 2020. During year ended June 30, 2018, the Company purchased 0.3 million shares of its common stock on the open market at an aggregate purchase price of $1.5 million under this repurchase program. At June 30, 2018, there is $3.5 million remaining under this repurchase program. The Company’s Articles of Incorporation authorize the issuance of preferred shares. However, as of June 30, 2018, none have been issued nor have any rights or preferences been assigned to the preferred shares by the Company’s Board of Directors.

Share-Based Compensation

12 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Long-Term Incentive Plans

Equity-Settled Plans

The Company adopted, and the shareholders approved, the 2007 Long-Term Incentive Plan (the “2007 Plan”), effective November 21, 2006, to provide incentives to certain eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company’s common stock can be issued under the 2007 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2007 Plan and are outstanding to various employees, officers, directors, Scientific Advisory Board members and independent distributors at prices between $1.47 and $10.50 per share, with initial vesting periods of one to three years. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2007 Plan upon expiration of the award. The contractual term of stock options granted is generally ten years. As of June 30, 2018, there were stock option awards outstanding, net of awards expired, for the purchase in aggregate of 0.2 million shares of the Company’s common stock. Effective November 21, 2016, no new awards can be granted under the 2007 Plan.

The Company adopted, and the shareholders approved, the 2010 Long-Term Incentive Plan (the “2010 Plan”), effective September 27, 2010, as amended on August 21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.5 million shares of the Company’s common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $5.60 and $20.09 per share, and vest over one to four year vesting periods. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2010 Plan upon expiration of the award. The contractual term of stock options granted is generally ten years. As of June 30, 2018, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company’s common stock. No new awards will be granted under the 2010 Plan and forfeited or terminated shares will be added to the 2017 Plan pool as described below.

The Company adopted, and the shareholders approved, the 2017 Long-Term Incentive Plan (the “2017 Plan”), effective February 16, 2017 to provide incentives to eligible employees, directors and consultants. On February 2, 2018, the shareholders approved an amendment to the 2017 Plan to increase by 425,000 shares the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. The maximum number of shares that can be issued under the 2017 Plan is not to exceed 1,550,000 shares, calculated as the sum of (i) 1,075,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. As of June 30, 2018, a maximum of 1.5 million shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards. Outstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2017 Plan upon expiration of the award. The contractual term of stock options granted are substantially the same as described above for the 2007 Plan and 2010 Plan. As of June 30, 2018, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.5 million shares of the Company’s common stock.

Cash-Settled Plans

Performance Units

The Company adopted a performance incentive plan effective July 1, 2015 (the "Fiscal 2016 Performance Plan"). The Fiscal 2016 Performance Plan is intended to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company’s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Fiscal 2016 Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the “Units”). No shares will be issued under the Fiscal 2016 Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in three installments if the Company meets certain performance criteria generally set for each year of a three-year performance period. The service-based vesting criteria occurs in a single installment at the end of the third fiscal year after the awards are granted if the participant has continuously remained in service from the date of award through the end of the third fiscal year. The fair value of these awards is based on the trading price of the Company's common stock and is remeasured at each reporting period date until settlement. The Company adopted separate performance incentive plans effective July 1, 2016 (the "Fiscal 2017 Performance Plan") and July 1, 2017 (the "Fiscal 2018 Performance Plan"). The Fiscal 2017 Performance Plan and Fiscal 2018 Performance Plan include performance-based and service-based vesting requirements and payment terms that are substantially the same as described above for the Fiscal 2016 Performance Plan.

Phantom Units

During the fiscal year ended June 30, 2018, the Company awarded phantom units to its executive officers and senior management. The vesting date for the phantom units is December 31, 2018, at which time the units will be settled in cash equal to (i) the number of vested units multiplied by (ii) the positive difference (if any) between the value at December 31, 2018 and $4.76, the closing price of the Company's common stock on the start date. The start date is December 29, 2017, the last business day of calendar year 2017. The fair value of these awards is based on the Black Scholes valuation model and is remeasured at each reporting period date until settlement.

Stock-Based Compensation

In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal years ended June 30, 2018, 2017 and 2016, stock-based compensation of $3.0 million, $2.3 million and $2.0 million, respectively, was reflected as an increase to additional paid in capital and $0.2 million, $0.7 million and $0.7 million, respectively, was reflected as an increase to other accrued expenses, all of which was employee related.

At June 30, 2018, there was $2.7 million of unrecognized compensation cost related to nonvested share-based compensation arrangements under the 2010 and 2017 Plans, based on management's estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of 1.57 years.

Stock Options

During the fiscal year ended June 30, 2018, the Company awarded stock options ("FY 2018 Stock Options") to its executive officers and senior management. The vesting period for the FY 2018 Stock Options is three years and occurs as follows: (1) one-third of the total number of shares awarded vest on January 1, 2019; (2) one-twelfth of the total number of shares awarded vest on the last day of each fiscal quarter following January 1, 2019. The fair value of the stock options will be recognized on a straight-line basis over the requisite service period of the awards.

There were no stock option grants during the fiscal years ended June 30, 2017 and 2016.

The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair value as follows:



	June 30, 2018
Weighted-average grant date fair value	$	2.25
Risk-free interest rate	2.3		%
Expected volatility	59.0		%
Expected life (years)	4.7

The following is a summary of stock option activity for the fiscal years ended June 30, 2018, 2017 and 2016:



	Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2015	462		$	7.87

Granted	—		$	—
Exercised	(46	)	5.66			$	209
Forfeited	(33	)	17.85
Expired or Canceled	—		—
Outstanding at June 30, 2016	383		7.28

Granted	—		$	—
Exercised	(4	)	4.14			$	17
Forfeited	(62	)	12.64
Expired or Canceled	(7	)	2.45
Outstanding at June 30, 2017	310		6.35

Granted	461		$	4.44
Exercised	(21	)	2.96			$	33
Forfeited	(20	)	16.26
Expired or Canceled	—		—
Outstanding at June 30, 2018	730		4.96		6.69	$	1,310
Exercisable at June 30, 2018	268		$	5.86	1.70	$	420

Restricted Shares

The following is a summary of restricted shares granted during the fiscal years ended June 30, 2018, 2017 and 2016:



Nonvested Shares	Shares (in thousands)		Weighted Average Grant Date Fair Value
Nonvested at June 30, 2015	250		$	9.36

Granted	60		$	5.94
Vested	(40	)	15.64
Forfeited	(39	)	16.21
Nonvested at June 30, 2016	231		6.24
Vested at June 30, 2016	—		—

Granted	156		$	5.81
Vested	(88	)	8.31
Forfeited	(22	)	10.70
Nonvested at June 30, 2017	277		4.98
Vested at June 30, 2017	—		—

Granted	190		$	4.57
Vested	(355	)	4.62
Forfeited	(3	)	5.22
Nonvested at June 30, 2018	109		5.43
Vested at June 30, 2018	—		$	—

The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2018, 2017 and 2016 was $1.6 million, $0.7 million and $0.4 million, respectively.

Performance Restricted Stock Units

During the fiscal years ended June 30, 2017 and 2016, the Company awarded performance restricted stock units ("FY 2017 Performance Stock Units" and "FY 2016 Performance Stock Units") to its executive officers and senior management (the "Recipients"). Vesting for the FY 2017 Performance Stock Units and FY 2016 Performance Stock Units occurs in a single installment and is achieved at the end of the three year performance period if the participant has continuously remained in service from the date of the award through the end of the performance period. Each performance restricted stock unit represents a contingent right for the Recipient to receive, within thirty days after the end of the performance period, a distribution of shares of common stock of the Company equal to 0% to 200% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company's total stockholder return ("TSR") performance during the relevant performance period, subject to acceleration upon a change in control of the Company. The vesting for 50% of the target performance restricted stock units is based upon the Company's absolute TSR for the performance period as compared to a matrix of fixed numeric values and the vesting for the other 50% of the target performance restricted stock units is based upon the relative comparison of the Company's TSR to the Vanguard Russell 2000 exchange traded fund TSR. The fair value of the performance restricted stock units will be recognized on a straight-line basis over the requisite service period of the awards, regardless of when, if ever, the market-based performance conditions are satisfied.

No performance restricted stock units were granted during the fiscal year ended June 30, 2018. The fair values of performance restricted stock units granted during the fiscal years ended June 30, 2017 and 2016 were estimated using a Monte Carlo simulation model which included the following assumptions in order to reflect the performance conditions that must be satisfied for the share units to vest:



	June 30, 2017		June 30, 2016
Risk-free interest rate	1.5	%	1.3	%
Dividend yield	—	%	—	%
Expected volatility - Company	62.0	%	55.5	%
Expected volatility - peer company	17.1	%	15.7	%
Total measurement period (years)	2.8		3.0

The following is a summary of performance restricted stock units granted during the fiscal years ended June 30, 2018, 2017 and 2016:



	Number of Units (in thousands)		Weighted Average Grant Date Fair Value
Nonvested at June 30, 2015	115		$	10.76

Granted	848		$	12.30
Vested	(15	)	10.76
Forfeited	(485	)	11.25
Nonvested at June 30, 2016	463		13.07

Granted	420		$	4.69
Vested	(10	)	10.76
Forfeited	(111	)	12.86
Nonvested at June 30, 2017	762		8.51

Granted	—		$	—
Vested	—		—
Forfeited	(132	)	7.02
Nonvested at June 30, 2018	630		8.82
Vested at June 30, 2018	—		$	—

No performance restricted stock units vested during the fiscal year ended June 30, 2018. The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2017 and 2016 was $0.1 million and $0.1 million, respectively.

Cash-Settled Performance Units

The following is a summary of cash-settled performance units granted during the fiscal years ended June 30, 2018, 2017 and 2016:



	Number of Units (in thousands)		Weighted Average Grant Date Fair Value
Outstanding at June 30, 2015, nonvested	—

Granted	77		$	8.47
Vested	(13	)	—
Forfeited	(13	)	$	8.30
Outstanding at June 30, 2016, nonvested	51

Granted	95		$	13.17
Vested	(25	)	—
Forfeited	(89	)	$	12.43
Outstanding at June 30, 2017, nonvested	32

Granted	87		$	4.65
Vested	(32	)	—
Forfeited	(29	)	$	6.48
Outstanding at June 30, 2018, nonvested	58

The fair value of vested awards under the cash-settled performance plan for the fiscal years ended June 30, 2018, 2017 and 2016 was $0.2 million, $0.1 million and $0.2 million, respectively. Payments of $0.2 million, $0.2 million and $0.1 million were made to settle vested cash-settled performance units during the fiscal years ended June 30, 2018, 2017 and 2016, respectively.

Cash-Settled Phantom Units

The fair value of phantom unit awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair value as follows:



	June 30, 2018
Weighted-average grant date fair value	$	0.40
Risk-free interest rate	2.1% - 2.3%
Expected volatility	56.2% - 57.0%
Expected life (years)	0.5 - 0.8

The following is a summary of cash-settled phantom units granted during the fiscal year ended June 30, 2018:



	Number of Units (in thousands)	Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2017, nonvested	—

Granted	170
Vested	—
Forfeited	—
Outstanding at June 30, 2018, nonvested	170	0.50	$	273

No phantom units were outstanding as of June 30, 2017 and 2016.

Warrants

As of June 30, 2018, the Company had no outstanding warrants.

The following is a summary of the warrant activity for the fiscal years ended June 30, 2018, 2017 and 2016 (in thousands):



	Common Stock Warrants
Outstanding and exercisable, June 30, 2015	87

Issued	—
Canceled	—
Exercised	(7	)
Expired	—
Outstanding and exercisable, June 30, 2016	80

Issued	—
Canceled	—
Exercised	(80	)
Expired	—
Outstanding and exercisable, June 30, 2017	—

Issued	—
Canceled	—
Exercised	—
Expired	—
Outstanding and exercisable, June 30, 2018	—

As of June 30, 2018, 2017 and 2016, the Company had no warrants classified as derivative liabilities.

Income Taxes

12 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

The income tax expense for the fiscal years ended June 30, 2018, 2017 and 2016 consists of the following (in thousands):



	Year ended June 30,
	2018		2017			2016

Income Before Income Taxes:
Domestic	$	8,234	$	1,642		$	7,518
International	1,315		1,268			1,166
	$	9,549	$	2,910		$	8,684
Current Taxes:
Federal	$	2,413	$	1,324		$	4,180
State	407		137			561
Foreign	150		510			455
Total Current Income Tax Provision	$	2,970	$	1,971		$	5,196
Deferred Taxes:
Federal	$	377	$	(473	)	$	(2,326	)
State	59		(21		)	(105		)
Foreign	381		(175		)	(187		)
Total Deferred Income Tax Provision	$	817	$	(669	)	$	(2,618	)
Net Income Tax Provision	$	3,787	$	1,302		$	2,578

The effective income tax rate for the fiscal years ended June 30, 2018, 2017 and 2016 differs from the U.S. Federal statutory income tax rate due to the following:



	Year ended June 30,
	2018		2017		2016

Federal statutory income tax rate	28.0	%	34.0	%	35.0	%
State income taxes, net of federal benefit	2.5	%	5.9	%	2.8	%
Foreign tax rate difference	1.6	%	(4.6	)%	(2.3	)%
Tax return to provision true-up	(7.4	)%	0.6	%	0.7	%
Other differences	0.2	%	(2.1	)%	0.0	%
Revalue of deferred for change in federal tax rate	14.9	%	0.0	%	0.0	%
Permanent differences:
— stock based compensation	0.7	%	4.6	%	0.9	%
— domestic production activities deduction	(1.5	)%	(3.3	)%	(4.4	)%
— tax credits	(1.3	)%	(0.9	)%	(0.7	)%
— meals and entertainment	0.9	%	3.4	%	1.0	%
— penalties	0.1	%	1.5	%	0.0	%
— other	0.9	%	4.3	%	(3.9	)%
Change in valuation allowance	0.1	%	1.3	%	0.6	%
Net income tax provision	39.7	%	44.7	%	29.7	%

The components of the deferred tax assets and liabilities as of June 30, 2018 and 2017 are as follows (in thousands):



	June 30,
	2018			2017

Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$	574		$	536
Stock option compensation	1,367			1,531
Accrued vacation, allowance for returns, bonuses & other	2,615			3,173
Gross deferred tax asset	$	4,556		$	5,240

Deferred tax liabilities:
Patents and trademarks	$	(145	)	$	(253	)
Property & equipment	(823		)	(588		)
Other	(13		)	—
Gross deferred tax liabilities	(981		)	(841		)
Less: valuation allowance	(320		)	(312		)
Deferred tax assets, net	$	3,255		$	4,087

The Tax Cuts and Jobs Act of 2017 (the " 2017 Tax Act"), which became effective December 22, 2017, overhauls U.S. corporate income tax law by lowering the U.S. federal corporate income tax rate from 35% to 21% (blended rate in year one for fiscal year filers), implementing a territorial tax system, imposing a one time "deemed repatriation" tax on all untaxed offshore earnings, and adding/modifying/deleting several major tax deductions significant to the Company.

In addition, the 2017 Tax Act also includes a provision to tax global intangible low-taxed income ("GILTI") of foreign subsidiaries and a base erosion anti-abuse tax ("BEAT") measure that taxes certain payments between a U.S. Corporation and its subsidiaries. The Company will not be subject to these provisions until its fiscal 2019 tax year. Preliminary analysis suggests that the Company will not have a GILTI liability and that it will not meet the threshold to be subject to BEAT nor does it currently make the types of payments that are subject to BEAT.

The Company has done detailed analysis and computation to determine the impacts of the 2017 Tax Act to its financial statements. The Company has recorded the following items as part of its fiscal 2018 income tax provision (in thousands):



Revalue of Deferred Tax Assets for the Corporate Tax Rate Change	$	1,419
Deemed Repatriation Tax on All Untaxed Offshore Earnings	$	—

The Company was able to utilize its unborn foreign tax credits, mainly in Japan, to reduce its tax liability on its deemed repatriated earnings to zero. Any unused unborn foreign tax credits will be unavailable for future use.

Deferred tax assets and liabilities measure the expected amounts that tax expense will increase or decrease by in the future due to temporary differences between book and tax basis. The Company has significant deferred tax assets, meaning we expect to receive a tax deduction in the future, mainly related to stock compensation and fixed assets. These tax assets were valued at a 35% federal rate. When the 2017 Tax Act was enacted, these deferred assets will now give rise to a tax deduction at a 21% rate. This means that the Company will receive less benefit in the future for its deferred tax assets. Therefore, it recognized a one-time tax expense of $1.4 million to reflect this revaluation.

The Company has adopted accounting guidance for uncertain tax positions which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit. We believe the Company has no material uncertain tax positions and do not expect significant changes within the next twelve months in the amount of unrecognized tax benefits. Accordingly, we have not reserved for interest or penalties. The tax years open for examination by the Internal Revenue Service (“IRS”) include returns for fiscal years June 30, 2015 through present and the open tax years by state tax authorities include returns for fiscal years June 30, 2014 through present. In addition, the IRS and state tax authorities may examine NOL’s for any previous years if utilized by the Company.

As of June 30, 2018, the Company had utilized all of its Federal net operating loss (“NOL”) carry-forwards. The net operating losses were to expire by June 30, 2024 and are subject to review by the Internal Revenue Service, and are subject to U.S. Internal Revenue Code Section 382 limitations. As of June 30, 2018, state NOLs were $8.2 million and foreign NOLs were $1.0 million.

The total recognized tax benefit from settlement of stock based awards for the period ending June 30, 2018 was $0.5 million.

The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2014 through June 30, 2018.

Commitments and Contingencies

12 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Operating Leases

The Company leases its facilities under non-cancelable operating leases, which expire at various dates through 2024. The facilities leases contain renewal options and are subject to cost increases. Future minimum annual payments under non-cancelable operating leases at June 30, 2018 are as follows (in thousands):



Year ending June 30,	Amount
2019	$	2,815
2020	2,837
2021	1,589
2022	1,379
2023	1,423
Thereafter	968
Total future minimum lease payments	$	11,011

Rent expense totaled $2.7 million, $2.5 million and $2.3 million for the fiscal years ended June 30, 2018, 2017 and 2016, respectively.

Contingencies

The Company accounts for contingent liabilities in accordance with Accounting Standards Codification ("ASC") Topic 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June 30, 2018, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.

Legal Accruals

In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the Company's normal conduct of business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.

Class Action Lawsuit (Smith v. LifeVantage Corp.): On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, plaintiff alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.

Class Action Lawsuit (Zhang v. LifeVantage Corp.): As previously reported, on September 15, 2016, a purported securities class action was filed in the United States District Court for the District of Utah, entitled Zhang v. LifeVantage Corp., Case No. 2:16-cv-00965-BCW (D. Utah filed Sept. 15, 2016). In this action (later recaptioned as In re LifeVantage Corp. Securities Litigation), plaintiff alleged that the Company, its Chief Executive Officer and former Chief Financial Officer violated Sections 10(b) and/or 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b), 78t(a), and Rule 10b-5, 17 C.F.R. § 240.10b-5, promulgated thereunder. On June 15, 2017, the Court granted defendants’ motion to dismiss the amended complaint, without prejudice, and permitted lead plaintiffs to file a motion for leave to file a second amended complaint. On September 18, 2017, the Court denied lead plaintiffs’ motion for leave to amend and entered final judgment in favor of LifeVantage and the other defendants and dismissed the case with prejudice. On October 17, 2017, the parties executed a stipulation whereby lead plaintiffs agreed not to take an appeal from the final judgment of dismissal in favor of defendants in exchange for mutual releases, without payment of any consideration by or on behalf of defendants. This case is now concluded.

Derivative Action Lawsuits: Also, as previously reported, on October 11, 2016, two purported shareholder derivative actions were filed in the Third District Court of the State of Utah, Salt Lake County, entitled Johnson v. Jensen, Case No. 160906320 MI (Utah Dist. filed Oct. 11, 2016), and Rupp v. Jensen, Case No. 160906321 MI (Utah Dist. filed Oct. 11, 2016). In these actions (which are substantively identical), plaintiffs, purportedly on behalf of the Company, alleged that the Company’s Chief Executive Officer, former Chief Financial Officer and members of the board of directors breached their fiduciary duties owed to the Company in connection with the matters alleged in the securities class action lawsuit noted above. On October 19, 2016, the Court entered an order consolidating the two actions under the Johnson case number, with the new caption In re LifeVantage Corp. Derivative Litigation.

On January 30, 2017, another purported shareholder derivative action was filed in the United States District Court for the District of Utah, entitled Hansen v. Jensen, Case No. 2:17 cv-00075-DN (D. Utah filed Jan. 30, 2017). In this action, plaintiff, purportedly on behalf of the Company, alleged that the Company’s Chief Executive Officer, former Chief Financial Officer and members of the board of directors violated Section 14(a) of the Securities Exchange Act of 1934, 15 U.S.C. § 78n(a), and breached their fiduciary duties owed to the Company in connection with the matters alleged in the securities class action lawsuit noted above. On February 27, 2017, another purported shareholder derivative action was filed in the United States District Court for the District of Utah, entitled Baker v. Jensen, Case No. 2:17-cv-00141-PMW (D. Utah filed Feb. 27, 2017). Also, on April 24, 2017, another purported shareholder derivative action was filed in the United States District Court for the District of Utah, entitled Inforzato v. Jensen, Case No. 2:17-cv-00317-JNP (D. Utah filed Apr. 24, 2017). In these actions, plaintiffs, also purportedly on behalf of the Company, made similar allegations as the plaintiff in Hansen v. Jensen.

Following and in light of the dismissal with prejudice of the securities class action lawsuit noted above, the Company requested that the plaintiffs in the shareholder derivative actions agree to dismiss their lawsuits voluntarily and without payment of any consideration by or on behalf of defendants or the Company. On October 31, 2017, the plaintiffs in In re LifeVantage Corp. Derivative Litigation stipulated to voluntary dismissal of their consolidated action without payment of any consideration by or on behalf of defendants or the Company. On November 17, 2017, the parties in Inforzato, Hansen and Baker stipulated to voluntary dismissal of those actions without payment of any consideration by or on behalf of defendants or the Company.

On November 20, 2017, the Courts in In re LifeVantage Corp. Derivative Litigation and Hansen granted the stipulated motions to dismiss, and on December 12, 2017, the Court in Baker granted the stipulated motion to dismiss. On November 27, 2017, the Court in Inforzato ordered, pursuant to Rule 23.1(c) of the Federal Rules of Civil Procedure, that the parties give notice to shareholders of the voluntary dismissal without prejudice of the Inforzato action before the Inforzato action could be dismissed, which the Company provided on January 8, 2018. On April 5, 2018, the last remaining derivative lawsuit, the Inforzato action, was dismissed without prejudice.

Other Matters. In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this Annual Report on Form 10-K, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.

Related Party Transactions	12 Months Ended
Related Party Transactions	Jun. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Effective January 2014, the Company commenced a partnership with Real Salt Lake of Major League Soccer, which includes the placement of the Company's logo on the front of the team’s jersey as well as strategic placement of the Company's logo around the stadium and on televised broadcasts of the games. In July 2015, Dell Loy Hansen, the sole owner of Real Salt Lake and Real Monarchs SLC, became a major stockholder of the Company. During the fiscal years ended June 30, 2018, 2017 and 2016, the Company paid $4.0 million, $2.2 million and $2.8 million, respectively, to Real Salt Lake, pursuant to the terms of this partnership, and other various amounts for the endorsement of Real Monarchs SLC and for product marketing expenses. During fiscal 2017, Dinng, a brand and digital brand studio, provided branding and marketing services to the Company. In June 2017, the Company completed an acquisition of the assets of Dinng. The Company's Chief Marketing Officer, Ryan Goodwin, was the Founder, President and Creative Director of Dinng. The Company paid a total of $0.5 million for branding and marketing services provided during fiscal 2017 and the asset acquisition. The Company paid $0.5 million for branding and marketing services provided during fiscal 2016. During fiscal 2018, no payments were made by the Company to Dinng. During fiscal 2017, Outhink Inc., a digital media and application development company, provided consulting services to the Company pursuant to an agreement for services dated October 20, 2016 between the Company and Outhink Inc. in the amount of $0.1 million. David Toole, who served as a member of the Company's board of directors until February 2, 2018, is a majority owner and serves as the Chief Executive Officer of Outhink Inc. During the fiscal years ended June 30, 2018 and 2017, the Company paid $3.0 million and $0.4 million, respectively, to Gig Economy Group ("GEG") for outsourced software application development services, pursuant to an agreement entered into between the Company and GEG. During fiscal 2016, no payments were made by the Company to GEG. David Toole, who served as a member of the Company's board of directors until February 2, 2018, is a majority owner and an officer of GEG.

Interim Financial Results (Unaudited)

12 Months Ended

Jun. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Interim Financial Results (Unaudited)

The following summarizes selected quarterly financial information for quarterly periods during the fiscal years ended June 30, 2018 and 2017:

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED QUARTERLY RESULTS

(in thousands except per share data)



	Fiscal Quarter								Year ended June 30, 2018
	First		Second		Third		Fourth		Year ended June 30, 2018
Revenue, net	$	49,127	$	49,482	$	50,562	$	54,033	$	203,204
Gross profit	40,388		40,365		41,641		45,962		168,356
Net income	$	817	$	317	$	1,635	$	2,992	$	5,761
Per common share:
Income per share, basic	$	0.06	$	0.02	$	0.12	$	0.20	$	0.41
Income per share, diluted	$	0.06	$	0.02	$	0.12	$	0.21	$	0.41



	Fiscal Quarter								Year ended June 30, 2017
	First		Second		Third		Fourth		Year ended June 30, 2017
Revenue, net	$	54,894	$	48,947	$	45,007	$	50,641	$	199,489
Gross profit	46,062		41,447		36,774		41,750		166,033
Net income	$	1,180	$	283	$	61	$	84	$	1,608
Per common share:
Income per share, basic	$	0.09	$	0.02	$	0.00	$	0.01	$	0.12
Income per share, diluted	$	0.08	$	0.02	$	0.00	$	0.01	$	0.11

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Consolidation

Use of Estimates

Foreign Currency Translation

Fair Value of Financial Instruments

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less to be cash and cash equivalents.

Accounts Receivable

Inventory

Inventories are carried and depicted above at the lower of cost or market, using the first-in, first-out method

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:



	Years
Equipment (includes computer hardware and software)	3
Furniture and fixtures	5
Vehicles	5

Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term.

Intangible Assets

Impairment of Long-Lived Assets

Concentration of Credit Risk

Revenue Recognition

Commissions and Incentives

Shipping and Handling

Research and Development Costs

The Company expenses all costs related to research and development activities as incurred.

Stock-Based Compensation

Income Taxes

Income Per Share

Segment Information

New Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Components of inventory

As of June 30, 2018 and 2017, inventory consisted of (in thousands):



	June 30,
	2018		2017
Finished goods	$	7,859	$	7,817
Raw materials	5,768		8,758
Total inventory	$	13,627	$	16,575

Property and equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:



	Years
Equipment (includes computer hardware and software)	3
Furniture and fixtures	5
Vehicles	5

Property and equipment, net consist of (in thousands):



	June 30,
	2018			2017
Equipment (includes computer hardware and software)	$	10,504		$	7,420
Furniture and fixtures	1,592			1,536
Leasehold improvements	3,761			3,421
Vehicles	51			51
Accumulated depreciation	(9,321		)	(9,301		)
Total property and equipment, net	$	6,587		$	3,127

Reconciliation of earnings per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share



	Years ended June 30,
	2018		2017		2016

Numerator:
Net income	$	5,761	$	1,608	$	6,106
Denominator:
Basic weighted-average common shares outstanding	13,992		13,881		13,730
Effect of dilutive securities:
Stock awards and options	144		237		735
Warrants	—		—		66
Diluted weighted-average common shares outstanding	14,136		14,118		14,531
Net income per share, basic	$	0.41	$	0.12	$	0.44
Net income per share, diluted	$	0.41	$	0.11	$	0.42

Revenues from unaffiliated customers by geographic regions and significant geographic area

Revenues by geographic area are as follows (in thousands):



	Years ended June 30,
	2018		2017		2016
Americas	$	151,609	$	150,841	$	158,291
Asia/Pacific & Europe	51,595		48,648		48,249
Total revenues	$	203,204	$	199,489	$	206,540

Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):



	Years ended June 30,
	2018		2017		2016
United States	$	142,452	$	144,842	$	152,830
Japan	$	41,843	$	39,390	$	36,343

Revenues by major product line

The following table shows revenues by major product line for the fiscal years ended June 30, 2018, 2017 and 2016.



	Years ended June 30,
	2018				2017				2016
Protandim^®product line	$	133,923	65.9	%	$	130,873	65.6	%	$	128,019	62.0	%
TrueScience^®product line	21,665		10.7	%	24,440		12.3	%	32,914		15.9	%
Other	47,616		23.4	%	44,176		22.1	%	45,607		22.1	%
Total	$	203,204	100.0	%	$	199,489	100.0	%	$	206,540	100.0	%

Property and Equipment, Net (Tables)

12 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property and equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:



	Years
Equipment (includes computer hardware and software)	3
Furniture and fixtures	5
Vehicles	5

Property and equipment, net consist of (in thousands):



	June 30,
	2018			2017
Equipment (includes computer hardware and software)	$	10,504		$	7,420
Furniture and fixtures	1,592			1,536
Leasehold improvements	3,761			3,421
Vehicles	51			51
Accumulated depreciation	(9,321		)	(9,301		)
Total property and equipment, net	$	6,587		$	3,127

Share-Based Compensation (Tables)

12 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Options Fair Value Valuation Assumptions

The fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair value as follows:



	June 30, 2018
Weighted-average grant date fair value	$	2.25
Risk-free interest rate	2.3		%
Expected volatility	59.0		%
Expected life (years)	4.7

Summary of Stock Option Activity

The following is a summary of stock option activity for the fiscal years ended June 30, 2018, 2017 and 2016:



	Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2015	462		$	7.87

Granted	—		$	—
Exercised	(46	)	5.66			$	209
Forfeited	(33	)	17.85
Expired or Canceled	—		—
Outstanding at June 30, 2016	383		7.28

Granted	—		$	—
Exercised	(4	)	4.14			$	17
Forfeited	(62	)	12.64
Expired or Canceled	(7	)	2.45
Outstanding at June 30, 2017	310		6.35

Granted	461		$	4.44
Exercised	(21	)	2.96			$	33
Forfeited	(20	)	16.26
Expired or Canceled	—		—
Outstanding at June 30, 2018	730		4.96		6.69	$	1,310
Exercisable at June 30, 2018	268		$	5.86	1.70	$	420

Schedule of Nonvested Restricted Shares

The following is a summary of restricted shares granted during the fiscal years ended June 30, 2018, 2017 and 2016:



Nonvested Shares	Shares (in thousands)		Weighted Average Grant Date Fair Value
Nonvested at June 30, 2015	250		$	9.36

Granted	60		$	5.94
Vested	(40	)	15.64
Forfeited	(39	)	16.21
Nonvested at June 30, 2016	231		6.24
Vested at June 30, 2016	—		—

Granted	156		$	5.81
Vested	(88	)	8.31
Forfeited	(22	)	10.70
Nonvested at June 30, 2017	277		4.98
Vested at June 30, 2017	—		—

Granted	190		$	4.57
Vested	(355	)	4.62
Forfeited	(3	)	5.22
Nonvested at June 30, 2018	109		5.43
Vested at June 30, 2018	—		$	—

Share-based Awards Other Than Options Fair Value Valuation Assumptions

The fair value of phantom unit awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair value as follows:



	June 30, 2018
Weighted-average grant date fair value	$	0.40
Risk-free interest rate	2.1% - 2.3%
Expected volatility	56.2% - 57.0%
Expected life (years)	0.5 - 0.8

The fair values of performance restricted stock units granted during the fiscal years ended June 30, 2017 and 2016 were estimated using a Monte Carlo simulation model which included the following assumptions in order to reflect the performance conditions that must be satisfied for the share units to vest:



	June 30, 2017		June 30, 2016
Risk-free interest rate	1.5	%	1.3	%
Dividend yield	—	%	—	%
Expected volatility - Company	62.0	%	55.5	%
Expected volatility - peer company	17.1	%	15.7	%
Total measurement period (years)	2.8		3.0

Summary of Nonvested Restricted Stock Units

The following is a summary of performance restricted stock units granted during the fiscal years ended June 30, 2018, 2017 and 2016:



	Number of Units (in thousands)		Weighted Average Grant Date Fair Value
Nonvested at June 30, 2015	115		$	10.76

Granted	848		$	12.30
Vested	(15	)	10.76
Forfeited	(485	)	11.25
Nonvested at June 30, 2016	463		13.07

Granted	420		$	4.69
Vested	(10	)	10.76
Forfeited	(111	)	12.86
Nonvested at June 30, 2017	762		8.51

Granted	—		$	—
Vested	—		—
Forfeited	(132	)	7.02
Nonvested at June 30, 2018	630		8.82
Vested at June 30, 2018	—		$	—

Schedule of Performance Share Units Activity

The following is a summary of cash-settled performance units granted during the fiscal years ended June 30, 2018, 2017 and 2016:



	Number of Units (in thousands)		Weighted Average Grant Date Fair Value
Outstanding at June 30, 2015, nonvested	—

Granted	77		$	8.47
Vested	(13	)	—
Forfeited	(13	)	$	8.30
Outstanding at June 30, 2016, nonvested	51

Granted	95		$	13.17
Vested	(25	)	—
Forfeited	(89	)	$	12.43
Outstanding at June 30, 2017, nonvested	32

Granted	87		$	4.65
Vested	(32	)	—
Forfeited	(29	)	$	6.48
Outstanding at June 30, 2018, nonvested	58

Summary of Cash-Settled Phantom Units

The following is a summary of cash-settled phantom units granted during the fiscal year ended June 30, 2018:



	Number of Units (in thousands)	Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2017, nonvested	—

Granted	170
Vested	—
Forfeited	—
Outstanding at June 30, 2018, nonvested	170	0.50	$	273

Summary of the Warrants Granted

The following is a summary of the warrant activity for the fiscal years ended June 30, 2018, 2017 and 2016 (in thousands):



	Common Stock Warrants
Outstanding and exercisable, June 30, 2015	87

Issued	—
Canceled	—
Exercised	(7	)
Expired	—
Outstanding and exercisable, June 30, 2016	80

Issued	—
Canceled	—
Exercised	(80	)
Expired	—
Outstanding and exercisable, June 30, 2017	—

Issued	—
Canceled	—
Exercised	—
Expired	—
Outstanding and exercisable, June 30, 2018	—

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Components of Income Tax Expense

The income tax expense for the fiscal years ended June 30, 2018, 2017 and 2016 consists of the following (in thousands):



	Year ended June 30,
	2018		2017			2016

Income Before Income Taxes:
Domestic	$	8,234	$	1,642		$	7,518
International	1,315		1,268			1,166
	$	9,549	$	2,910		$	8,684
Current Taxes:
Federal	$	2,413	$	1,324		$	4,180
State	407		137			561
Foreign	150		510			455
Total Current Income Tax Provision	$	2,970	$	1,971		$	5,196
Deferred Taxes:
Federal	$	377	$	(473	)	$	(2,326	)
State	59		(21		)	(105		)
Foreign	381		(175		)	(187		)
Total Deferred Income Tax Provision	$	817	$	(669	)	$	(2,618	)
Net Income Tax Provision	$	3,787	$	1,302		$	2,578

The Company has recorded the following items as part of its fiscal 2018 income tax provision (in thousands):



Revalue of Deferred Tax Assets for the Corporate Tax Rate Change	$	1,419
Deemed Repatriation Tax on All Untaxed Offshore Earnings	$	—

The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate

The effective income tax rate for the fiscal years ended June 30, 2018, 2017 and 2016 differs from the U.S. Federal statutory income tax rate due to the following:



	Year ended June 30,
	2018		2017		2016

Federal statutory income tax rate	28.0	%	34.0	%	35.0	%
State income taxes, net of federal benefit	2.5	%	5.9	%	2.8	%
Foreign tax rate difference	1.6	%	(4.6	)%	(2.3	)%
Tax return to provision true-up	(7.4	)%	0.6	%	0.7	%
Other differences	0.2	%	(2.1	)%	0.0	%
Revalue of deferred for change in federal tax rate	14.9	%	0.0	%	0.0	%
Permanent differences:
— stock based compensation	0.7	%	4.6	%	0.9	%
— domestic production activities deduction	(1.5	)%	(3.3	)%	(4.4	)%
— tax credits	(1.3	)%	(0.9	)%	(0.7	)%
— meals and entertainment	0.9	%	3.4	%	1.0	%
— penalties	0.1	%	1.5	%	0.0	%
— other	0.9	%	4.3	%	(3.9	)%
Change in valuation allowance	0.1	%	1.3	%	0.6	%
Net income tax provision	39.7	%	44.7	%	29.7	%

The Components of the Deferred Tax Assets and Liabilities

The components of the deferred tax assets and liabilities as of June 30, 2018 and 2017 are as follows (in thousands):



	June 30,
	2018			2017

Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$	574		$	536
Stock option compensation	1,367			1,531
Accrued vacation, allowance for returns, bonuses & other	2,615			3,173
Gross deferred tax asset	$	4,556		$	5,240

Deferred tax liabilities:
Patents and trademarks	$	(145	)	$	(253	)
Property & equipment	(823		)	(588		)
Other	(13		)	—
Gross deferred tax liabilities	(981		)	(841		)
Less: valuation allowance	(320		)	(312		)
Deferred tax assets, net	$	3,255		$	4,087

Interim Financial Results (Unaudited) (Tables)

12 Months Ended

Jun. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Summary of selected quarterly financial information

The following summarizes selected quarterly financial information for quarterly periods during the fiscal years ended June 30, 2018 and 2017:

LIFEVANTAGE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED QUARTERLY RESULTS

(in thousands except per share data)



	Fiscal Quarter								Year ended June 30, 2018
	First		Second		Third		Fourth		Year ended June 30, 2018
Revenue, net	$	49,127	$	49,482	$	50,562	$	54,033	$	203,204
Gross profit	40,388		40,365		41,641		45,962		168,356
Net income	$	817	$	317	$	1,635	$	2,992	$	5,761
Per common share:
Income per share, basic	$	0.06	$	0.02	$	0.12	$	0.20	$	0.41
Income per share, diluted	$	0.06	$	0.02	$	0.12	$	0.21	$	0.41



	Fiscal Quarter								Year ended June 30, 2017
	First		Second		Third		Fourth		Year ended June 30, 2017
Revenue, net	$	54,894	$	48,947	$	45,007	$	50,641	$	199,489
Gross profit	46,062		41,447		36,774		41,750		166,033
Net income	$	1,180	$	283	$	61	$	84	$	1,608
Per common share:
Income per share, basic	$	0.09	$	0.02	$	0.00	$	0.01	$	0.12
Income per share, diluted	$	0.08	$	0.02	$	0.00	$	0.01	$	0.11

Summary of Significant Accounting Policies - Narrative (Details)		12 Months Ended
	Oct. 19, 2015	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Summary of Significant Accounting Policies Additional Information [Abstract]
Recorded bad debt expense		$ 0	$ 0	$ 0
Impairment of intangible assets		0
Loss from write-off of intangible assets		$ 0	350,000	0
Money back guarantee period		30 days
Percentage of products can be returned for a full refund by terminated distributors		30.00%
Restocking fee percent for full refund (percent)		10.00%
Reserve balance for returns and allowances		$ 400,000	400,000
Research and development		$ 1,200,000	$ 1,100,000	$ 1,000,000
Stock split ratio	7
Blended tax rate		28.00%	34.00%	35.00%
Cash Accounts Held Primarily At Financial Institution
Summary of Significant Accounting Policies Additional Information [Abstract]
Concentration of credit risk		$ 11,400,000
Cash Accounts Held at Other Financial Institutions
Summary of Significant Accounting Policies Additional Information [Abstract]
Concentration of credit risk		$ 5,300,000

Summary of Significant Accounting Policies - Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Components of Inventory
Finished goods	$ 7,859	$ 7,817
Raw materials	5,768	8,758
Total inventory	13,627	16,575
Inventory valuation reserves	$ 1,400	$ 900

Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Property, Plant and Equipment [Line Items]
Loss on disposal of fixed assets	$ 0	$ 0	$ 1,186,000
Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Estimated service lives of Property and Equipment	3 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated service lives of Property and Equipment	5 years
Vehicles
Property, Plant and Equipment [Line Items]
Estimated service lives of Property and Equipment	5 years

Summary of Significant Accounting Policies - Reconciliation of Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Accounting Policies [Abstract]
Number of antidilutive securities (in shares)									400	200
Numerator:
Net income	$ 2,992	$ 1,635	$ 317	$ 817	$ 84	$ 61	$ 283	$ 1,180	$ 5,761	$ 1,608	$ 6,106
Denominator:
Basic weighted-average common shares outstanding (in shares)									13,992	13,881	13,730
Effect of dilutive securities:
Stock awards and options (in shares)									144	237	735
Warrants (in shares)									0	0	66
Diluted weighted-average common shares outstanding (in shares)									14,136	14,118	14,531
Net income per share, basic (dollars per share)	$ 0.20	$ 0.12	$ 0.02	$ 0.06	$ 0.01	$ 0.00	$ 0.02	$ 0.09	$ 0.41	$ 0.12	$ 0.44
Net income per share, diluted (dollars per share)	$ 0.21	$ 0.12	$ 0.02	$ 0.06	$ 0.01	$ 0.00	$ 0.02	$ 0.08	$ 0.41	$ 0.11	$ 0.42

Summary of Significant Accounting Policies - Revenues by Geographic Area (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Mar. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2018 USD ($) Segment	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of geographic segments \| Segment									2
Revenues from unaffiliated customers
Total revenues	$ 54,033	$ 50,562	$ 49,482	$ 49,127	$ 50,641	$ 45,007	$ 48,947	$ 54,894	$ 203,204	$ 199,489	$ 206,540
Americas
Revenues from unaffiliated customers
Total revenues									151,609	150,841	158,291
Asia/Pacific & Europe
Revenues from unaffiliated customers
Total revenues									51,595	48,648	48,249
United States
Segment Reporting Information [Line Items]
Long-lived assets	9,800				6,200				9,800	6,200
Revenues from unaffiliated customers
Total revenues									142,452	144,842	152,830
Japan
Segment Reporting Information [Line Items]
Long-lived assets	$ 900				$ 900				900	900
Revenues from unaffiliated customers
Total revenues									$ 41,843	$ 39,390	$ 36,343

Summary of Significant Accounting Policies - Revenues by Major Products (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2018 USD ($) product_line	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)
Revenue from External Customer [Line Items]
Number of product lines \| product_line	2
Revenues	$ 203,204	$ 199,489	$ 206,540
Revenues percentage	100.00%	100.00%	100.00%
Product Concentration Risk \| Sale Revenues, Gross
Revenue from External Customer [Line Items]
Concentration risk, percentage	76.60%	77.90%	77.90%
Protandim® product line
Revenue from External Customer [Line Items]
Revenues	$ 133,923	$ 130,873	$ 128,019
Revenues percentage	65.90%	65.60%	62.00%
TrueScience® product line
Revenue from External Customer [Line Items]
Revenues	$ 21,665	$ 24,440	$ 32,914
Revenues percentage	10.70%	12.30%	15.90%
Other
Revenue from External Customer [Line Items]
Revenues	$ 47,616	$ 44,176	$ 45,607
Revenues percentage	23.40%	22.10%	22.10%

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (9,321)	$ (9,301)
Total property and equipment, net	6,587	3,127
Depreciation expense	1,200	1,500	$ 1,800
Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Property and equipment, gross	10,504	7,420
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,592	1,536
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,761	3,421
Vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 51	$ 51

Intangible Assets, Net (Details) - USD ($) $ in Thousands	12 Months Ended
Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, net	$ 1,115	$ 1,247
Amortization of intangible assets	$ 100	100	$ 100
Definite-lived intangible assets weighted-average amortization period	6 years 9 months
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]
2019	$ 100
2020	100
2021	100
2022	100
2023	100
Patent costs
Finite-Lived Intangible Assets [Line Items]
Patent costs	2,330	2,330
Accumulated amortization	(1,460)	(1,328)
Total definite-lived intangible assets, net	870	1,002
Trademark costs
Finite-Lived Intangible Assets [Line Items]
Trademarks and other indefinite-lived intangible assets	$ 245	$ 245

Other Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Payables and Accruals [Abstract]
Accrued incentive compensation	$ 2,868	$ 1,151
Accrued other expenses	2,087	2,853
Other taxes payable	1,884	1,517
Accrued incentives and promotions to distributors	1,366	988
Deferred revenue	1,107	1,743
Accrued payroll and other employee expenses	1,095	1,201
Total other accrued expenses	$ 10,407	$ 9,453

Long-Term Debt - Narrative (Details)	12 Months Ended
Long-Term Debt - Narrative (Details)	Jun. 30, 2018 USD ($)	May 04, 2018 USD ($)	Mar. 30, 2016 USD ($)
March 2016 Term Loan \| Secured Debt
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 10,000,000
Frequency of periodic payment	quarterly
Periodic principal payment	$ 500,000
Fixed interest rate		5.68%	4.93%
Fixed charge coverage ratio		1.25	1.50
Minimum working capital		$ 8,000,000	$ 5,000,000
Total liabilities to tangible net worth ratio		3.00
March 2016 Revolving Loan \| Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 2,000,000

Long-Term Debt - Future Principal Payments (Details) $ in Thousands	Jun. 30, 2018 USD ($)
Debt Disclosure [Abstract]
2019	$ 2,000
2020	2,000
2021	1,500
Total debt	$ 5,500

Stockholders' Equity (Details) - USD ($)	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Nov. 27, 2017
Class of Stock [Line Items]
Repurchase common stock amount authorized				$ 5,000,000
Stock repurchased during period (in shares)	300,000
Payments for repurchase of common stock	$ 1,500,000	$ 0	$ 0
Remaining authorized amount of common stock repurchase program	$ 3,500,000
Common Stock
Class of Stock [Line Items]
Common stock issued (in shares)	21,000	76,000	52,000
Restricted common stock to employees (in shares)	190,000	166,000	76,000
Shares canceled or surrendered as payment of tax withholding (shares)	66,000	38,000	58,000
Stock repurchased during period (in shares)	304,000

Share-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands					12 Months Ended
	Feb. 02, 2018 shares	Jul. 01, 2014 Vesting_Installlment	Sep. 27, 2010 $ / shares shares	Nov. 21, 2006 $ / shares shares	Jun. 30, 2018 USD ($) $ / shares shares	Jun. 30, 2017 USD ($) shares	Jun. 30, 2016 USD ($) shares	Dec. 29, 2017 $ / shares	Jun. 30, 2015 shares
Equity Incentive Plans
Share price (in dollars per share) \| $ / shares								$ 4.76
Stock-Based Compensation
Stock based compensation \| $					$ 2,990	$ 2,315	$ 1,966
Stock-based compensation awards classified as a liability settled in cash \| $					$ 200	$ 700	$ 700
Options granted (in shares)							0
Phantom Units
Stock-Based Compensation
Shares granted (in shares)					170,000
Shares vested (in shares)					0
Number of units outstanding (in shares)					170,000	0	0
Restricted Stock
Stock-Based Compensation
Shares granted (in shares)					190,000	156,000	60,000
Shares vested (in shares)					355,000	88,000	40,000
Number of units outstanding (in shares)					109,000	277,000	231,000		250,000
Employee Stock Option
Equity Incentive Plans
Vesting period of Long-Term Incentive Plan					3 years
Company's common stock purchased in aggregate (in shares)					730,000	310,000	383,000		462,000
Stock-Based Compensation
Options granted (in shares)					461,000	0	0
Performance Restricted Stock Units
Equity Incentive Plans
Vesting period of Long-Term Incentive Plan						3 years	3 years
Stock-Based Compensation
Shares granted (in shares)					0	420,000	848,000
Distribution period following performance period							30 days
Shares vested (in shares)					0	10,000	15,000
Number of units outstanding (in shares)					630,000	762,000	463,000		115,000
Company's TSR Compared to a Matrix \| Performance Restricted Stock Units
Stock-Based Compensation
Vesting right percentage							50.00%
Company's TSR Compared to Vanguard Russell 2000 Exchange Trade Fund \| Performance Restricted Stock Units
Stock-Based Compensation
Vesting right percentage							50.00%
Minimum \| Performance Restricted Stock Units
Stock-Based Compensation
Distribution percentage of target number of Performance Stock Units							0.00%
Maximum \| Performance Restricted Stock Units
Stock-Based Compensation
Distribution percentage of target number of Performance Stock Units							200.00%
2007 Long-Term Incentive Plan
Equity Incentive Plans
Maximum common stock issued under Long-Term Incentive Plan (in shares)				1,428,571
Contractual term of stock options granted				10 years
2007 Long-Term Incentive Plan \| Minimum
Equity Incentive Plans
Right to purchase common stock, minimum price (dollars per share) \| $ / shares				$ 1.47
Vesting period of Long-Term Incentive Plan				1 year
2007 Long-Term Incentive Plan \| Maximum
Equity Incentive Plans
Right to purchase common stock, minimum price (dollars per share) \| $ / shares				$ 10.50
Vesting period of Long-Term Incentive Plan				3 years
Company's common stock purchased in aggregate (in shares)					200,000
2010 Long-Term Incentive Plan
Equity Incentive Plans
Maximum common stock issued under Long-Term Incentive Plan (in shares)	475,000		1,500,000
Contractual term of stock options granted			10 years
Company's common stock purchased in aggregate (in shares)					100,000
2010 Long-Term Incentive Plan \| Restricted Stock
Stock-Based Compensation
Unrecognized compensation cost \| $					$ 2,700
Period for recognition of unrecognized compensation cost					1 year 6 months 25 days
2010 Long-Term Incentive Plan \| Minimum
Equity Incentive Plans
Right to purchase common stock, minimum price (dollars per share) \| $ / shares			$ 5.60
Vesting period of Long-Term Incentive Plan			1 year
2010 Long-Term Incentive Plan \| Maximum
Equity Incentive Plans
Right to purchase common stock, minimum price (dollars per share) \| $ / shares			$ 20.09
Vesting period of Long-Term Incentive Plan			4 years
2017 Long-Term Incentive Plan
Equity Incentive Plans
Maximum common stock issued under Long-Term Incentive Plan (in shares)	1,550,000				1,500,000
Vesting period of Long-Term Incentive Plan					3 years
Company's common stock purchased in aggregate (in shares)					500,000
Number of additional shares authorized	425,000
Exercise price of outstanding stock options (in dollars per share) \| $ / shares					$ 4.44
2017 Long Term Incentive Plan Excluding 2010 Long Term Incentive Plan
Equity Incentive Plans
Maximum common stock issued under Long-Term Incentive Plan (in shares)	1,075,000
2014 Performance Incentive Plan
Equity Incentive Plans
Number of vesting installments \| Vesting_Installlment		3
Vesting period of Long-Term Incentive Plan		3 years

Share-Based Compensation - Valuation Assumptions (Details) - $ / shares	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value (in dollars per share)	$ 2.25
Risk-free interest rate	2.30%
Expected volatility - Company	59.00%
Total measurement period (years)	4 years 8 months 12 days
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value (in dollars per share)	$ 0.00	$ 4.69	$ 12.30
Risk-free interest rate		1.50%	1.30%
Dividend yield		0.00%	0.00%
Expected volatility - Company		62.00%	55.50%
Expected volatility - peer company		17.10%	15.70%
Total measurement period (years)		2 years 9 months	3 years
Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value (in dollars per share)	$ 0.40
Minimum \| Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.10%
Expected volatility - Company	56.20%
Total measurement period (years)	6 months
Maximum \| Phantom Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.30%
Expected volatility - Company	57.00%
Total measurement period (years)	9 months 18 days

Share-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Summary of Stock Option Activity (shares)
Options, Granted (in shares)			0
Employee Stock Option
Summary of Stock Option Activity (shares)
Options, Outstanding beginning balance (in shares)	310,000	383,000	462,000
Options, Granted (in shares)	461,000	0	0
Options, Exercised (in shares)	(21,000)	(4,000)	(46,000)
Options, Forfeited (in shares)	(20,000)	(62,000)	(33,000)
Options, Expired or canceled (in shares)	0	(7,000)	0
Options, Outstanding ending balance (in shares)	730,000	310,000	383,000
Weighted Average Exercise Price (dollars per share)
Weighted average exercise price, Outstanding beginning balance (dollars per share)	$ 6.35	$ 7.28	$ 7.87
Weighted average exercise price, Granted (dollars per share)	4.44	0.00	0.00
Weighted average exercise price, Exercised (dollars per share)	2.96	4.14	5.66
Weighted average exercise price, Forfeited (dollars per share)	16.26	12.64	17.85
Weighted average exercise price, Expired or canceled (dollars per share)	0.00	2.45	0.00
Weighted average exercise price, Outstanding ending balance (dollars per share)	$ 4.96	$ 6.35	$ 7.28
Weighted Average Remaining Contractual Term
Weighted average remaining contractual term, Outstanding	6 years 8 months 10 days
Additional Disclosures
Options, Exercisable (shares)	268,000
Weighted average exercise price, Exercisable (dollars per share)	$ 5.86
Weighted average remaining contractual term, Exercisable	1 year 8 months 12 days
Aggregate intrinsic value, Exercised	$ 33	$ 17	$ 209
Aggregate intrinsic value, Outstanding ending balance	1,310
Aggregate intrinsic value, Exercisable	$ 420

Share-Based Compensation - Restricted Shares (Details) - Restricted Shares - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares outstanding beginning period (in shares)	277	231	250
Shares granted (in shares)	190	156	60
Shares vested (in shares)	(355)	(88)	(40)
Shares forfeited (in shares)	(3)	(22)	(39)
Shares outstanding ending period (in shares)	109	277	231
Vested shares (in shares)	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, beginning period (dollars per share)	$ 4.98	$ 6.24	$ 9.36
Weighted average grant date fair value, granted (dollars per share)	4.57	5.81	5.94
Weighted average grant date fair value, vested and issued (dollars per share)	4.62	8.31	15.64
Weighted average grant date fair value, forfeited (dollars per share)	5.22	10.70	16.21
Weighted average grant date fair value, ending period (dollars per share)	5.43	4.98	6.24
Weighted average granted date fair value, vested shares (dollars per share)	$ 0.00	$ 0.00	$ 0.00
Fair value of vested awards	$ 1.6	$ 0.7	$ 0.4

Share-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares outstanding beginning period (in shares)	762,000	463,000	115,000
Shares granted (in shares)	0	420,000	848,000
Shares vested (in shares)	0	(10,000)	(15,000)
Shares forfeited (in shares)	(132,000)	(111,000)	(485,000)
Shares outstanding ending period (in shares)	630,000	762,000	463,000
Vested shares (in shares)	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, beginning period (dollars per share)	$ 8.51	$ 13.07	$ 10.76
Weighted average grant date fair value, granted (dollars per share)	0.00	4.69	12.30
Weighted average grant date fair value, vested and issued (dollars per share)	0.00	10.76	10.76
Weighted average grant date fair value, forfeited (dollars per share)	7.02	12.86	11.25
Weighted average grant date fair value, ending period (dollars per share)	8.82	$ 8.51	$ 13.07
Weighted average granted date fair value, vested shares (dollars per share)	$ 0.00
Fair value of vested awards		$ 0.1	$ 0.1

Share-Based Compensation - Cash-Settled Performance Units (Details) - Cash-Settled Performance Units - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares outstanding beginning period (in shares)	32	51	0
Shares granted (in shares)	87	95	77
Shares vested (in shares)	(32)	(25)	(13)
Shares forfeited (in shares)	(29)	(89)	(13)
Shares outstanding ending period (in shares)	58	32	51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, granted (dollars per share)	$ 4.65	$ 13.17	$ 8.47
Weighted average grant date fair value, vested and issued (dollars per share)	0.00	0.00	0.00
Weighted average grant date fair value, forfeited (dollars per share)	$ 6.48	$ 12.43	$ 8.30
Fair value of vested awards	$ 0.2	$ 0.1	$ 0.2
Payments made to settle vested performance share units	$ 0.2	$ 0.2	$ 0.1

Share-Based Compensation - Cash-Settled Phantom Units (Details) - Phantom Units - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares outstanding beginning period (in shares)	0	0
Shares granted (in shares)	170,000
Shares vested (in shares)	0
Shares forfeited (in shares)	0
Shares outstanding ending period (in shares)	170,000	0
Weighted average remaining contractual term, Outstanding	6 months
Aggregate intrinsic value, Outstanding ending balance	$ 273

Share-Based Compensation - Summary of Warrants (Details) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Outstanding warrants (in shares)	0
Warrants
Summary of the warrants issued
Outstanding and exercisable, Beginning balance (in shares)	0	80,000	87,000
Issued (in shares)	0	0	0
Canceled (in shares)	0	0	0
Exercised (in shares)	0	(80,000)	(7,000)
Expired (in shares)	0	0	0
Outstanding and exercisable, Ending balance (in shares)	0	0	80,000
Warrants - Derivative Liability
Summary of the warrants issued
Warrants classified as derivative liabilities	$ 0	$ 0	$ 0

Other Expense, Net (Details) - USD ($) $ in Thousands	12 Months Ended
Other Expense, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Other Income and Expenses [Abstract]
Foreign currency transaction loss, net	$ (92)	$ (182)	$ (11)
Loss on settlement of forward contract	(175)	(292)	(212)
Loss on disposal of fixed assets	(6)	(12)	(1,186)
Write-off of intangible assets	0	(350)	0
Other expense, net	(46)	(133)	0
Total other expense, net	$ (319)	$ (969)	$ (1,409)

Income Taxes - Narrative (Details) $ in Thousands	12 Months Ended
Income Taxes - Narrative (Details) $ in Thousands	Jun. 30, 2018 USD ($)
Operating Loss Carryforwards [Line Items]
Revalue of Deferred Tax Assets for the Corporate Tax Rate Change	$ 1,419
Tax benefit from settlement of stock based awards	500
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	8,200
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 1,000

Income Taxes - Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Income Before Income Taxes:
Domestic	$ 8,234	$ 1,642	$ 7,518
International	1,315	1,268	1,166
Income / (Loss) Before Income Taxes	9,549	2,910	8,684
Current Taxes:
Federal	2,413	1,324	4,180
State	407	137	561
Foreign	150	510	455
Total Current Income Tax Provision	2,970	1,971	5,196
Deferred Taxes:
Federal	377	(473)	(2,326)
State	59	(21)	(105)
Foreign	381	(175)	(187)
Total Deferred Income Tax Provision	817	(669)	(2,618)
Net Income Tax Provision	$ 3,787	$ 1,302	$ 2,578

Income Taxes - Effective Income tax Rate (Details)	12 Months Ended
Income Taxes - Effective Income tax Rate (Details)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
The effective income tax rate differs from the U.S. Federal statutory income tax rate
Federal statutory income tax rate	28.00%	34.00%	35.00%
State income taxes, net of federal benefit	2.50%	5.90%	2.80%
Foreign tax rate difference	1.60%	(4.60%)	(2.30%)
Tax return to provision true-up	(7.40%)	0.60%	0.70%
Other differences	0.20%	(2.10%)	0.00%
Revalue of deferred for change in federal tax rate	14.90%	0.00%	0.00%
Permanent differences:
— stock based compensation	0.70%	4.60%	0.90%
— domestic production activities deduction	(1.50%)	(3.30%)	(4.40%)
— tax credits	(1.30%)	(0.90%)	(0.70%)
— meals and entertainment	0.90%	3.40%	1.00%
— penalties	0.10%	1.50%	0.00%
— other	0.90%	4.30%	(3.90%)
Change in valuation allowance	0.10%	1.30%	0.60%
Net income tax provision	39.70%	44.70%	29.70%

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017
Deferred tax assets:
Federal, state, and foreign net operating loss carryovers	$ 574	$ 536
Stock option compensation	1,367	1,531
Accrued vacation, allowance for returns, bonuses & other	2,615	3,173
Gross deferred tax asset	4,556	5,240
Deferred tax liabilities:
Patents and trademarks	(145)	(253)
Property & equipment	(823)	(588)
Other	(13)	0
Gross deferred tax liabilities	(981)	(841)
Less: valuation allowance	(320)	(312)
Deferred tax assets, net	$ 3,255	$ 4,087

Income Taxes - Impact of 2017 Tax Act (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2018 USD ($)
Income Tax Disclosure [Abstract]
Revalue of Deferred Tax Assets for the Corporate Tax Rate Change	$ 1,419
Deemed Repatriation Tax on All Untaxed Offshore Earnings	$ 0

Commitments and Contingencies - Operating Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Future minimum lease payments under the non-cancelable leases
2019	$ 2,815
2020	2,837
2021	1,589
2022	1,379
2023	1,423
Thereafter	968
Total future minimum lease payments	11,011
Rent expense	$ 2,700	$ 2,500	$ 2,300

Related Party Transactions (Details) - USD ($)	12 Months Ended
Related Party Transactions (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Real Salt Lake \| Partnership Terms
Related Party Transaction [Line Items]
Related party transaction, amount of transaction	$ 4,000,000	$ 2,200,000	$ 2,800,000
Dinng \| Branding and Marketing Services
Related Party Transaction [Line Items]
Related party transaction, amount of transaction	0	500,000	500,000
Outhink Inc \| Consulting Services
Related Party Transaction [Line Items]
Related party transaction, amount of transaction		100,000
Gig Economy Group \| Software Application Development Services
Related Party Transaction [Line Items]
Related party transaction, amount of transaction	$ 3,000,000	$ 400,000	$ 0

Interim Financial Results (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Summary of selected quarterly financial information
Revenue, net	$ 54,033	$ 50,562	$ 49,482	$ 49,127	$ 50,641	$ 45,007	$ 48,947	$ 54,894	$ 203,204	$ 199,489	$ 206,540
Gross profit	45,962	41,641	40,365	40,388	41,750	36,774	41,447	46,062	168,356	166,033	172,608
Net income	$ 2,992	$ 1,635	$ 317	$ 817	$ 84	$ 61	$ 283	$ 1,180	$ 5,761	$ 1,608	$ 6,106
Per common share:
Net income per share, basic (dollars per share)	$ 0.20	$ 0.12	$ 0.02	$ 0.06	$ 0.01	$ 0.00	$ 0.02	$ 0.09	$ 0.41	$ 0.12	$ 0.44
Net income per share, diluted (dollars per share)	$ 0.21	$ 0.12	$ 0.02	$ 0.06	$ 0.01	$ 0.00	$ 0.02	$ 0.08	$ 0.41	$ 0.11	$ 0.42

Commitments and Contingencies - Legal Accruals (Details)	Oct. 11, 2016 lawsuit
Johnson and Rupp vs Jensen \| Pending Litigation \| Alleged Breached Fiduciary Duties
Loss Contingencies [Line Items]
Number of shareholder derivative actions	2